中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2012, 24(9): 1019-1025
海洋药物藻酸双酯钠研究进展及启示
李春霞*,孙 杨,管华诗*
(中国海洋大学医药学院,海洋药物教育部重点实验室,山东省糖科学与糖工程重点实验室,青岛 266003)
摘 要:通过总结我国自主研发的第一个海洋药物藻酸双酯钠(propylene glycol alginate sodium sulfate, PSS)近30年的生产和临床应用情况,对其生产工艺和质量标准、药理活性、临床用药和不良反应等进行系统深入的探讨,阐明PSS的构效关系和作用机制,以期进行PSS产品的更新换代,提高市场竞争力,扩大PSS临床新的适应症等,从而实现对PSS的技术改造和升级,进一步为广大患者提供更加安全有效的海洋药物,为海洋多糖类药物的研究与开发提供参考。
关键词:海洋药物;藻酸双酯钠;临床应用
 
Progress of marine drug propylene glycol alginate sodium sulfate (PSS) and inspiration
LI Chun-Xia*, SUN Yang, GUAN Hua-Shi*
(Key Laboratory of Marine Drugs, Ministry of Education, Key Laboratory of Glycoscience and Glycotechnology of Shandong Province, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China)
Abstract: Propylene glycol alginate sodium sulfate (PSS), the first marine drug independently developed in China, had been in the clinical application for nearly three decades. In this paper production process and quality standards, pharmacological activities, clinical use and adverse reactions of the PSS were discussed thoroughly for clarification of its structure-activity relationship and mechanism of action. It is enlightened to upgrade the PSS and expand its new clinical indications to achieve the technological innovation and upgrade, which will provide our patients with more safe and effective marine drugs, provide a reference for drug research and development of marine polysaccharides.
Key words: marine drug; PSS; clinical application
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2952846 位访问者,欢迎!